Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Schneider

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Brain Injury|August 3, 2012
The influence of gender on the injury severity, course and outcome of traumatic brain injuryCaroline Renner, Horst Hummelsheim, Anna Kopczak, et al.
European Journal of Pharmacology|December 6, 2016
ADX71943 and ADX71441, novel positive allosteric modulators of the GABA<sub>B</sub> receptor with distinct central/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the ratMikhail Kalinichev, Tansy Donovan-Rodriguez, Françoise Girard, et al.
Frontiers in Endocrinology|January 9, 2019
Low Prevalence of Isolated Growth Hormone Deficiency in Patients After Brain Injury: Results From a Phase II Pilot StudyMiriam Leonhardt, Anna Kopczak, Barbara Schäpers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2025
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy ParticipantsRolf Pokorny, J Michael Ryan, Khalid Abd-Elaziz, et al.
Journal of Neurotrauma|June 16, 2011
Structured assessment of hypopituitarism after traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1242 patients: the German interdisciplinary databaseHarald J Schneider, Manfred Schneider, Ilonka Kreitschmann-Andermahr, et al.
Journal of Neurotrauma|February 26, 2016
Neuroendocrine Disturbances One to Five or More Years after Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage: Data from the German Database on HypopituitarismCarmen Krewer, Manfred Schneider, Harald Jörn Schneider, et al.
Journal of Neurogenetics|November 19, 2011
Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depressionBrice Campo, Mikhail Kalinichev, Nathalie Lambeng, et al.
Plos Neglected Tropical Diseases|July 7, 2020
Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitroMarc P Hübner, Coralie Martin, Sabine Specht, et al.
Journal of Medicinal Chemistry|September 16, 2011
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Adeline Prêtre, Catherine Jorand-Lebrun, et al.
Chemmedchem|March 5, 2015
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacyAnna Quattropani, Wolfgang H B Sauer, Stefano Crosignani, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Brain Injury|August 3, 2012
The influence of gender on the injury severity, course and outcome of traumatic brain injuryCaroline Renner, Horst Hummelsheim, Anna Kopczak, et al.
European Journal of Pharmacology|December 6, 2016
ADX71943 and ADX71441, novel positive allosteric modulators of the GABA<sub>B</sub> receptor with distinct central/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the ratMikhail Kalinichev, Tansy Donovan-Rodriguez, Françoise Girard, et al.
Frontiers in Endocrinology|January 9, 2019
Low Prevalence of Isolated Growth Hormone Deficiency in Patients After Brain Injury: Results From a Phase II Pilot StudyMiriam Leonhardt, Anna Kopczak, Barbara Schäpers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2025
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy ParticipantsRolf Pokorny, J Michael Ryan, Khalid Abd-Elaziz, et al.
Journal of Neurotrauma|June 16, 2011
Structured assessment of hypopituitarism after traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1242 patients: the German interdisciplinary databaseHarald J Schneider, Manfred Schneider, Ilonka Kreitschmann-Andermahr, et al.
Journal of Neurotrauma|February 26, 2016
Neuroendocrine Disturbances One to Five or More Years after Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage: Data from the German Database on HypopituitarismCarmen Krewer, Manfred Schneider, Harald Jörn Schneider, et al.
Journal of Neurogenetics|November 19, 2011
Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depressionBrice Campo, Mikhail Kalinichev, Nathalie Lambeng, et al.
Plos Neglected Tropical Diseases|July 7, 2020
Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitroMarc P Hübner, Coralie Martin, Sabine Specht, et al.
Journal of Medicinal Chemistry|September 16, 2011
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseasesStefano Crosignani, Adeline Prêtre, Catherine Jorand-Lebrun, et al.
Chemmedchem|March 5, 2015
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacyAnna Quattropani, Wolfgang H B Sauer, Stefano Crosignani, et al.
Pageof 3